Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005065 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00006929 | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | 82 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00028535 | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00055757 | Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00066768 | Suramin and Either Docetaxel or Gemcitabine in Treating Patients With Stage IIIB or Stage IV Platinum-Refractory Non-Small Cell Lung Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00118183 | Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | completed | Phase 1 | 5 | Bristol-Myers SquibbINDUSTRY | 5 | Jun 3, 2013 | clinicaltrials |
| NCT00104793 | Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00132054 | Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 30 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00662324 | Development of a Clinical Trial Specific Question Prompt List | completed | — | 67 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01079481 | Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer | completed | Phase 1 | 21 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01125995 | Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer | completed | Phase 3 | 222 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01130753 | Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer | completed | Phase 2 | 43 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00601796 | Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00653250 | Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | completed | N/A | 22 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | May 21, 2013 | clinicaltrials |
| NCT00855894 | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer(PENGUIN) | completed | Phase 2 | 41 | Genentech, Inc.INDUSTRY | 2 | May 21, 2013 | clinicaltrials |
| NCT00004176 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 34 | Washington University School of MedicineOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00002470 | Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors | completed | Phase 2 | — | Mid-Atlantic Oncology ProgramOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00021138 | Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking | completed | N/A | — | Personal Improvement Computer SystemsOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00077415 | 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 31 | Cancer Therapeutics Research GroupOTHER | 4 | May 15, 2013 | clinicaltrials |
| NCT00050973 | Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer | completed | Phase 3 | 623 | Eisai Inc.INDUSTRY | 11 | May 14, 2013 | clinicaltrials |
| NCT00411047 | Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 34 | Massachusetts General HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT00117442 | A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood | completed | Phase 2 | 61 | AmgenINDUSTRY | 0 | May 13, 2013 | clinicaltrials |
| NCT01141842 | Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity | completed | Phase 1 | 230 | Schillerhoehe HospitalOTHER | 1 | May 7, 2013 | clinicaltrials |
| NCT00293280 | Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 42 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00425646 | Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | University of WashingtonOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00002519 | Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer | completed | Phase 1 | 6 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 3, 2013 | clinicaltrials |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | Phase 1 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00006370 | Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer | completed | Phase 2 | 275 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00404365 | Depression Screening in Patients With Lung Cancer | completed | N/A | 241 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00002656 | Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00030407 | Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 34 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00030420 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 24 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00056004 | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | completed | Phase 2 | 38 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00068653 | Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 27 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00248482 | Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 6 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00716534 | Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 145 | AbbVie (prior sponsor, Abbott)INDUSTRY | 6 | Apr 29, 2013 | clinicaltrials |
| NCT01839032 | Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy | completed | Phase 2 | 70 | Pierre Fabre MedicamentINDUSTRY | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01837186 | Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC) | completed | — | 600 | University Hospital, GasthuisbergOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01837511 | Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients | completed | — | 377 | GlaxoSmithKlineINDUSTRY | 2 | Apr 23, 2013 | clinicaltrials |
| NCT01836575 | Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2(PS2) | completed | Phase 3 | 228 | Instituto Nacional de Cancer, BrazilOTHER_GOV | 2 | Apr 22, 2013 | clinicaltrials |
| NCT00003943 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | completed | Phase 2 | 3 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00021333 | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer | completed | Phase 2 | 29 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00276276 | Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer | completed | Phase 3 | 141 | GlaxoSmithKlineINDUSTRY | 6 | Apr 15, 2013 | clinicaltrials |
| NCT00004186 | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 55 | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00033384 | CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00897793 | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | completed | — | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00603538 | Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer | completed | Phase 1 | 19 | PfizerINDUSTRY | 1 | Apr 11, 2013 | clinicaltrials |
| NCT01829373 | Lung Cancer Vaccine Plus Oral Dietary Supplement | completed | Phase 1 | 5 | Edward HirschowitzOTHER | 1 | Apr 11, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 4, 2013source: clinicaltrials